- Home
- AMTB vs SLP Comparison
AMTB vs SLP Comparison
Compare AMTB & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTB
- SLP
- Stock Information
- Founded
- AMTB 1979
- SLP 1996
- Country
- AMTB United States
- SLP United States
- Employees
- AMTB N/A
- SLP N/A
- Industry
- AMTB Major Banks
- SLP EDP Services
- Sector
- AMTB Finance
- SLP Technology
- Exchange
- AMTB Nasdaq
- SLP Nasdaq
- Market Cap
- AMTB 756.7M
- SLP 675.9M
- IPO Year
- AMTB N/A
- SLP 1997
- Fundamental
- Price
- AMTB $16.67
- SLP $17.16
- Analyst Decision
- AMTB Hold
- SLP Buy
- Analyst Count
- AMTB 5
- SLP 7
- Target Price
- AMTB $24.33
- SLP $40.40
- AVG Volume (30 Days)
- AMTB 190.1K
- SLP 468.2K
- Earning Date
- AMTB 07-23-2025
- SLP 07-02-2025
- Dividend Yield
- AMTB 2.16%
- SLP 0.35%
- EPS Growth
- AMTB N/A
- SLP N/A
- EPS
- AMTB N/A
- SLP 0.36
- Revenue
- AMTB $280,716,000.00
- SLP $78,564,000.00
- Revenue This Year
- AMTB $57.57
- SLP $27.66
- Revenue Next Year
- AMTB $8.91
- SLP $6.75
- P/E Ratio
- AMTB N/A
- SLP $48.12
- Revenue Growth
- AMTB N/A
- SLP 21.49
- 52 Week Low
- AMTB $16.21
- SLP $17.04
- 52 Week High
- AMTB $27.00
- SLP $49.72
- Technical
- Relative Strength Index (RSI)
- AMTB 38.90
- SLP 18.67
- Support Level
- AMTB $16.50
- SLP $18.66
- Resistance Level
- AMTB $18.35
- SLP $28.65
- Average True Range (ATR)
- AMTB 0.42
- SLP 1.74
- MACD
- AMTB -0.07
- SLP -1.05
- Stochastic Oscillator
- AMTB 9.19
- SLP 3.78
About AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.